MetaVia Inc. (MTVA) Financials

MTVA Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 14.4 million 5.3 million
Dec. 31, 2025 69.1 million 63.8 million
Sept. 30, 2025 14.8 million 8.4 million
June 30, 2025 18.5 million 8.8 million

MTVA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.3 million 100000
Dec. 31, 2025 -4.9 million 71000
Sept. 30, 2025 -3.0 million 97000
June 30, 2025 -3.1 million 111000

MTVA Net Income

No data available :(

MTVA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 13.7 million - 123000
Dec. 31, 2025 10.3 million - 142000
Sept. 30, 2025 14.3 million - 79000
June 30, 2025 17.6 million - 98000

MTVA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.9 million
Dec. 31, 2025 2.3 million
Sept. 30, 2025 2.2 million
June 30, 2025 1.4 million

MTVA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 2.1 million 1.9 million -
Dec. 31, 2025 - 241000 1.8 million -
Sept. 30, 2025 - 1.9 million 1.6 million -
June 30, 2025 2000 2.3 million 2.0 million -

MTVA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 5000
Dec. 31, 2025 - 5000
Sept. 30, 2025 - -
June 30, 2025 - 5000

MTVA

Price: $1.48

52 week price:
0.97
19.03

Earnings Per Share: -4.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.3 million

Links: